Trial Profile
A Phase 2 combination trial of SPR741
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 06 Oct 2017
Price :
$35
*
At a glance
- Drugs SPR 741 (Primary)
- Indications Gram-negative infections
- Focus Therapeutic Use
- 06 Oct 2017 New trial record